Gefitinib (Iressa) Tablet – Treatment for Lung Cancer
Gefitinib or Iressa Tablet is a medication used to treat non-small cell lung cancer. It is used in individuals whose cancer has progressed to other regions of their bodies, who have faulty epidermal growth factor receptor genes, and who have not previously received cancer treatment. Iressa Tablet can be taken with or without meals, although it is best to take it at the same time each day for the best benefits. You should continue to take it for as long as your doctor recommends. The length of treatment depends on your needs and reaction to treatment. You should take it precisely as prescribed by your doctor. Taking it incorrectly or in excess might result in significant negative effects. It may take many weeks or months for you to notice or feel the advantages, but do not stop taking it until your doctor instructs you to do so.
Gefitinib is manufactured by AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology firm headquartered in Cambridge, England, on the Cambridge Biomedical Campus.
USES OF GEFITINIB (IRESSA) 250MG TABLET
- Non-small cell lung cancer
HOW GEFITINIB (IRESSA) 250MG TABLET WORKS
Gefitinib is a cancer-fighting drug. It works by preventing the aberrant protein from signaling cancer cells to proliferate. This aids in the prevention or slowing of the spread of cancer cells.
Fedelty Health Care is a certified Gefitinib Bulk Pharma Exporter, Cargo Bulk Supplier, and pharmaceutical wholesaler in India.
DIRECTIONS FOR USE
Take this medication at the dose and for the period prescribed by your doctor. Take it all at once. It should not be chewed, crushed, or broken. Gefitinib can be taken with or without meals, although it is best to take it at the same time every day.
SIDE EFFECTS OF GEFITINIB (IRESSA) 250MG TABLET
- Dry skin
- Loss of appetite
- Stomatitis (Inflammation of the mouth)
- Weight loss
WARNING & PRECAUTIONS
Gefitinib may have adverse effects that impair your ability to drive. Iressa Tablet may cause drowsiness. This might impair your driving skills.
In individuals with severe renal disease, Gefitinib should be taken with care. Iressa Tablet dosage may need to be adjusted. Please visit your physician.
In people with liver problems, Gefitinib or Iressa Tablet is most likely safe to take. Based on the current data, it appears that no dosage change of Gefitinib is required in these individuals. Please visit your physician.
Gefitinib should not be used during pregnancy since there is clear evidence of danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please visit your physician.
Fedelty Health Care is a Gefitinib bulk pharma exporter (Iressa Exporter) and pharmaceutical third-party manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.